因胃食管反流病行修正性减重手术:4412例回顾性队列的患者及手术因素与30天结局分析
基于MBSAQIP登记系统2020年4412例因胃食管反流病(GERD)行修正性减重手术的患者,占所有转换手术的24%,多数原手术为袖状胃切除术(3535例,80.1%),修正手术多为Roux-en-Y胃旁路术(3722例,84.4%)。30天内重大并发症527例(11.9%),死亡10例(0.23%)。多因素分析显示手术时长、术前抗酸药使用和Roux-en-Y胃旁路术是重大并发症的预测因素。
要点
- GERD是减重术后修正手术的第二常见指征,占所有转换手术的24%。
- 因GERD行修正手术者原手术多为袖状胃切除术(80.1%),修正方式多为Roux-en-Y胃旁路术(84.4%)。
- 30天重大并发症发生率11.9%,死亡0.23%,吻合口漏0.70%,消化道出血0.86%。
核心结论
- GERD是减重手术后修正手术的第二常见指征,原手术为袖状胃切除术者是因GERD行修正手术的主要群体,多数修正为Roux-en-Y胃旁路术。
- 需进一步研究以制定修正手术患者的手术方式和术前优化策略。
研究设计与样本
- 利用代谢与减重手术认证与质量改进项目(MBSAQIP)登记系统,回顾性识别2020年因GERD需行修正性减重手术的患者队列。
- 采用多因素logistic回归模型评估基线特征与并发症的相关性。
主要发现
- 4412例患者因GERD行修正手术,占所有转换手术的24%。
- 多数患者原手术为袖状胃切除术(n=3535,80.1%),修正手术多为Roux-en-Y胃旁路术(n=3722,84.4%)。
- 527例(11.9%)发生重大并发症,10例(0.23%)在修正手术后30天内死亡。
- 重大并发症包括吻合口漏31例(0.70%)和消化道出血38例(0.86%)。
- 多因素分析显示手术时长、术前抗酸药使用和Roux-en-Y胃旁路术是重大并发症的预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Gastroesophageal reflux disease (GERD) is a well-established potential consequence of bariatric surgery and can require revisional surgery. Our understanding of the population requiring revision is limited. In this study, we aim to characterize patients requiring revisional surgery for GERD to understand their perioperative risks and identify strategies to improve their outcomes. METHODS: Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) registry, a retrospective cohort of patients who required revisional surgery for GERD in 2020 was identified. Multivariable logistic regression modelling was used to assess correlations between baseline characteristics and morbidity. RESULTS: 4412 patients required revisional surgery for GERD, encompassing 24% of all conversion procedures. In most cases, patients underwent sleeve gastrectomy (SG) as their original surgery (n = 3535, 80.1%). The revisional surgery for most patients was a Roux-en-Y gastric bypass (RYGB) (n = 3722, 84.4%). Major complications occurred in 527 patients (11.9%) and 10 patients (0.23%) died within 30 days of revisional surgery. Major complications included anastomotic leak in 31 patients (0.70%) and gastrointestinal bleeding in 38 patients (0.86%). Multivariable analyses revealed that operative length, pre-operative antacid use, and RYGB were predictors of major complications. CONCLUSION: GERD is the second most common indication for revisional surgery in patients who have undergone bariatric surgery. Patients who underwent SG as their initial procedure were the primary group who required revisional surgery for GERD; most underwent revision via RYGB. Further inquiry is needed to tailor operative approaches and pre-operative optimization for revisional surgery patients.
引用
- MacVicar S, Mocanu V, Jogiat U, et al. Revisional bariatric surgery for gastroesophageal reflux disease: characterizing patient and procedural factors and 30-day outcomes for a retrospective cohort of 4412 patients. Surg Endosc. 2023. PMID: 37907658. doi:10.1007/s00464-023-10500-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。